期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 106, 期 2, 页码 173-181出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2014.08.009
关键词
Ketone bodies; Low carbohydrate; Acetylation; HDAC; Epigenetics
资金
- NIH/NIDDK [R24DK085610]
- Gladstone Institutes
- Larry L. Hillblom Foundation
- John A. Hartford Foundation
- Glenn Foundation for Medical Research
- NIH/NIA [5-T32-AG000212]
The ketone body beta-hydroxybutyrate (beta OHB) is a convenient carrier of energy from adipocytes to peripheral tissues during fasting or exercise. However, beta OHB is more than just a metabolite, having important cellular signaling roles as well. beta OHB is an endogenous inhibitor of histone deacetylases (HDACs) and a ligand for at least two cell surface receptors. In addition, the downstream products of beta OHB metabolism including acetyl-CoA, succinylCoA, and NAD+ (nicotinamide adenine dinucleotide) themselves have signaling activities. These regulatory functions of beta OHB serve to link the outside environment to cellular function and gene expression, and have important implications for the pathogenesis and treatment of metabolic diseases including type 2 diabetes. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据